Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Adicet Bio stock

Own Adicet Bio stock in just a few minutes.

Adicet Bio, Inc is an other business based in the US. Adicet Bio shares (ACET) are listed on the NASDAQ and all prices are listed in US Dollars. Adicet Bio employs 81 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Adicet Bio

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ACET – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Adicet Bio share price

Use our graph to track the performance of ACET stocks over time.

Adicet Bio shares at a glance

Information last updated 2021-04-30.
52-week range$9.71 - $21.40
50-day moving average $13.67
200-day moving average $13.57
Wall St. target price$26.40
PE ratio N/A
Dividend yield N/A (7.43%)
Earnings per share (TTM) N/A

Buy Adicet Bio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Adicet Bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Adicet Bio under- or over-valued?

Valuing Adicet Bio stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Adicet Bio's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Adicet Bio's PEG ratio

Adicet Bio's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.82. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Adicet Bio's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Adicet Bio financials

Revenue TTM $17.9 million
Gross profit TTM $17.9 million
Return on assets TTM -16.46%
Return on equity TTM -44.34%
Profit margin -204.87%
Book value $5.58
Market capitalisation $500.9 million

TTM: trailing 12 months

Shorting Adicet Bio shares

There are currently 451,368 Adicet Bio shares held short by investors – that's known as Adicet Bio's "short interest". This figure is 14% up from 396,037 last month.

There are a few different ways that this level of interest in shorting Adicet Bio shares can be evaluated.

Adicet Bio's "short interest ratio" (SIR)

Adicet Bio's "short interest ratio" (SIR) is the quantity of Adicet Bio shares currently shorted divided by the average quantity of Adicet Bio shares traded daily (recently around 151975.75757576). Adicet Bio's SIR currently stands at 2.97. In other words for every 100,000 Adicet Bio shares traded daily on the market, roughly 2970 shares are currently held short.

However Adicet Bio's short interest can also be evaluated against the total number of Adicet Bio shares, or, against the total number of tradable Adicet Bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Adicet Bio's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Adicet Bio shares in existence, roughly 10 shares are currently held short) or 0.0332% of the tradable shares (for every 100,000 tradable Adicet Bio shares, roughly 33 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Adicet Bio.

Find out more about how you can short Adicet Bio stock.

Adicet Bio share dividends

We're not expecting Adicet Bio to pay a dividend over the next 12 months.

Have Adicet Bio's shares ever split?

Adicet Bio's shares were split on a 1:7 basis on 15 September 2020. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Adicet Bio shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Adicet Bio shares which in turn could have impacted Adicet Bio's share price.

Adicet Bio overview

Adicet Bio, Inc. , a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase 1 clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors, including hepatocellular carcinoma, gastric cancer, and squamous cell carcinoma of the lung. The company is based in Boston, Massachusetts. .

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site